Clinical
Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin,
President and Chief Executive Officer, and Dr. Carol Reed, Executive
Vice President and Chief Medical Officer, will be presenting a corporate
overview at the Ninth Annual BMO Capital Markets’ Focus on Healthcare
Conference. The presentation will include updates on vilazodone,
in development for major depressive disorder and Stedivaze™,
a vasodilator in development for use in cardiac stress testing. Clinical
Data's presentation will take place at 8:30 a.m. EDT. on Wednesday,
August 5, 2009 at the Millennium Broadway Hotel, New York, NY.
A live audio and archived webcast of the Company presentation can be
accessed through the Company's website at www.clda.com.
About Clinical Data, Inc.
Clinical Data develops first-in-class and best-in-category targeted
therapeutics. The Company is advancing its late-stage drug candidates
for central nervous system disorders and cardiovascular diseases to be
followed by promising drug candidates in major therapeutic areas
including oncology and inflammatory diseases. Clinical Data plans to
differentiate its therapeutics by helping to predict and enhance
efficacy and tolerability by combining its drug development and
biomarker expertise to improve patient health and reduce costs. To learn
more, please visit the Company's website at www.clda.com.
Clinical Data, Inc.
Theresa McNeely, 617-527-9933 x3373
Vice
President
Corporate Communications
